Young David - Insider Non-Derivative Transactions at Processa Pharmaceuticals, Inc. (PCSA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 10, 2024, Young David's relationship to Processa Pharmaceuticals, Inc. (PCSA) is Director,Officer (Pres. Research & Development), and currently has 81,187 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PCSA insiders.

Data Source: SEC.
Young David - Insider Non-Derivative Transactions of PCSA Common Stock
Young David - Insider Non-Derivative Transactions at PCSA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 11, 2024 F -- (Common Stock) 282 1.71 80905
Jul 11, 2024 M -- (Common Stock) 644 0 81187
Apr 6, 2024 F -- (Common Stock) 518 2.79 80543
Apr 6, 2024 M -- (Common Stock) 1675 0 81061
Feb 8, 2024 P -- (Common Stock) 21000 2.45 79387
Feb 7, 2024 P -- (Common Stock) 20000 2.53 58387
Jan 2, 2024 F -- (Common Stock) 518 2.79 80544
Jan 2, 2024 M -- (Common Stock) 1675 0 81062
Oct 13, 2023 Acquisition -- (Common Stock) 155277 0.29 767701
Oct 11, 2023 Acquisition -- (Common Stock) 142000 0.24 612424
Jun 13, 2023 P -- (Common Stock) 40000 0.8 470424
Apr 15, 2023 P -- (Common Stock) 20000 0.55 430424
Apr 14, 2023 P -- (Common Stock) 20000 0.48 410424
Apr 13, 2023 P -- (Common Stock) 20000 0.45 390424
Apr 12, 2023 P -- (Common Stock) 20000 0.52 370424
Feb 10, 2023 Acquisition -- (Common Stock) 18750 0.8 350424